1. PROTAC Anti-infection Immunology/Inflammation
  2. PROTACs HIV Interleukin Related
  3. PROTAC SAMHD1 Degrader-1

PROTAC SAMHD1 Degrader-1 is an orally active targeted SAMHD1 PROTAC degrader, with an IC50 of 6.3 μM against the dNTP hydrolase activity of SAMHD1. PROTAC SAMHD1 Degrader-1 binds to SAMHD1 inside cells and mediates its degradation, with low off-target effects. PROTAC SAMHD1 Degrader-1 inhibits the production of pro-inflammatory cytokines and interferes with the cascade amplification process of inflammatory responses. PROTAC SAMHD1 Degrader-1 delays the progression of pulmonary fibrosis and exerts protective effects on lung tissues. PROTAC SAMHD1 Degrader-1 can be used in pulmonary fibrosis-related research. (Pink: SAMHD1 Target protein ligand (HY-182973); Blue: DCAF1 ligand (HY-182974); Black: linker (HY-W067705)).

For research use only. We do not sell to patients.

PROTAC SAMHD1 Degrader-1

PROTAC SAMHD1 Degrader-1 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All PROTACs Isoform Specific Products:

View All HIV Isoform Specific Products:

View All Interleukin Related Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

PROTAC SAMHD1 Degrader-1 is an orally active targeted SAMHD1 PROTAC degrader, with an IC50 of 6.3 μM against the dNTP hydrolase activity of SAMHD1. PROTAC SAMHD1 Degrader-1 binds to SAMHD1 inside cells and mediates its degradation, with low off-target effects. PROTAC SAMHD1 Degrader-1 inhibits the production of pro-inflammatory cytokines and interferes with the cascade amplification process of inflammatory responses. PROTAC SAMHD1 Degrader-1 delays the progression of pulmonary fibrosis and exerts protective effects on lung tissues. PROTAC SAMHD1 Degrader-1 can be used in pulmonary fibrosis-related research. (Pink: SAMHD1 Target protein ligand (HY-182973); Blue: DCAF1 ligand (HY-182974); Black: linker (HY-W067705))[1].

In Vitro

PROTAC SAMHD1 Degrader-1 (compound NP12) (0.15-10.0 μM; 6-48 h) induces dose- and time-dependent degradation of SAMHD1 in THP-1 cells, with a DC50 of 1.2 μM[1].
PROTAC SAMHD1 Degrader-1 (10 μM; 24 h pretreatment) increases the sensitivity of wild-type THP-1 cells to Ara-C, reducing the IC50 of Ara-C from 5.4 μM to 1.1 μM, which confirms that it inhibits SAMHD1 activity in cells[1].
PROTAC SAMHD1 Degrader-1 (1-10 μM; 1 h pretreatment) suppresses the production of LPS (HY-D1056)-induced proinflammatory cytokines (IL-1β, IL-6, TNF-α) in RAW264.7 macrophages in a concentration-dependent manner, and interferes with the transcription, translation and secretion of cytokines[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: THP-1 human acute monocytic leukemia cells
Concentration: 0.15, 0.3, 0.6, 1.2, 2.5, 5.1, 10.0 μM
Incubation Time: 6 h, 24 h, 48 h
Result: Induced 47.9%, 74.4%, and 91.8% SAMHD1 degradation at 1 μM, 2.5 μM, and 5 μM for 48 h, respectively.
Showed dose-dependent degradation across 0.15-10.0 μM for 48 h, with a DC50 of 1.2 μM.
Achieved 66% degradation at 24 h and maximum 89% degradation at 48 h with 5 μM treatment.
Maintained suppressed SAMHD1 levels for at least 24 h post-withdrawal of 5 μM treatment, with levels returning to near initial levels by 48 h post-withdrawal.
Parmacokinetics
Species Dose Route Cmax AUC0-t AUC0-∞ T1/2 CL Vss MRT0-∞ Tmax Bioavailability
Rat[1] 2 mg/kg i.v. 1226.5 ng/mL 2391.4 ng·h/mL 2941.1 ng·h/mL 3.9 h 837.5 mL/h/kg 2.9 L/kg 3.5 h / /
Rat[1] 30 mg/kg p.o. 437.3 ng/mL 5308.4 ng·h/mL 7165.5 ng·h/mL 3.5 h / / / 6.0 h 16.2 %
In Vivo

PROTAC SAMHD1 Degrader-1 (20-80 mg/kg; p.o.; once daily; for 14 consecutive days) induces dose-dependent degradation of SAMHD1 in mouse lung tissue, delays the progression of Bleomycin (HY-108345)-induced pulmonary fibrosis, alleviates lung tissue damage and collagen deposition, and reduces the levels of pro-inflammatory/pro-fibrotic cytokines[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 (male, 6-8 weeks old, 18-22 g, intratracheal bleomycin-induced pulmonary fibrosis)[1]
Dosage: 20 mg/kg; 40 mg/kg; 80 mg/kg
Administration: i.g.; daily; 14 days
Result: Showed gradual body weight recovery from day 9 onward.
Reduced bleomycin-induced lung tissue damage, including alleviated alveolar atrophy/collapse, bronchial wall thickening, and inflammatory cell infiltration.
Decreased collagen fiber deposition in a dose-dependent manner.
Significantly downregulated lung tissue expression of α-smooth muscle actin and fibronectin in a dose-dependent manner.
Reduced serum and bronchoalveolar lavage fluid levels of proinflammatory and profibrotic cytokines (IL-1β, IL-6, TGF-β1), with the 80 mg/kg dose showing the most pronounced effects.
Reduced lung tissue SAMHD1 protein levels to 80.7% (20 mg/kg), 58.3% (40 mg/kg), and 21.9% (80 mg/kg) of the control group, demonstrating dose-dependent degradation.
Molecular Weight

1080.64

Formula

C54H67ClFN13O8

SMILES

OCCCCN(N=C1)C(N=C2NC(CC3)CCN3CC(C=C4)=CC(Cl)=C4OC5=CC(NC(COCCOCCOCC(N(CC6)CCN6C7=CC(N[C@@H](C8)CCCN8C9=CC(F)=CC=C9)=NC=N7)=O)=O)=CC=C5)=C1C(N2)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
PROTAC SAMHD1 Degrader-1
Cat. No.:
HY-182970
Quantity:
MCE Japan Authorized Agent: